Patients presenting with supratherapeutic loperamide exposure appear to be at high risk for life-threatening dysrhythmias, and close cardiac monitoring should be broadly considered in this population. Management options include appropriate antiarrhythmic and cardiocirculatory support measures.
Building similarity graph...
Analyzing shared references across papers
Loading...
Elias Bekka
University Hospital of Bern
Adrian Martinez-De la Torre
Manuel Haschke
University of Bern
Clinical Toxicology
ETH Zurich
University Hospital of Zurich
University Hospital of Bern
Building similarity graph...
Analyzing shared references across papers
Loading...
Bekka et al. (Thu,) studied this question.
synapsesocial.com/papers/69b64c9ab42794e3e660dcd9 — DOI: https://doi.org/10.1080/15563650.2026.2634757